These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8223940)

  • 1. d-Fenfluramine- and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors.
    Gibson EL; Kennedy AJ; Curzon G
    Eur J Pharmacol; 1993 Sep; 242(1):83-90. PubMed ID: 8223940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release.
    Oluyomi AO; Gibson EL; Barnfield AM; Curzon G
    Eur J Pharmacol; 1994 Oct; 264(1):111-5. PubMed ID: 7828639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
    Vickers SP; Dourish CT; Kennett GA
    Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia.
    Kennett GA; Curzon G
    Br J Pharmacol; 1991 Aug; 103(4):2016-20. PubMed ID: 1912990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice.
    Lee MD; Somerville EM; Kennett GA; Dourish CT; Clifton PG
    Psychopharmacology (Berl); 2004 Oct; 176(1):39-49. PubMed ID: 15138762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of d-fenfluramine on feeding and hypothalamic 5-hydroxytryptamine and dopamine in male and female rats.
    Oluyomi AO; Datla KP; Curzon G
    Eur J Pharmacol; 1994 Apr; 255(1-3):175-83. PubMed ID: 7517881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
    Invernizzi R; Kmieciak-Kolada K; Samanin R
    Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding.
    Curzon G
    Adv Exp Med Biol; 1991; 294():377-88. PubMed ID: 1837683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.
    Callaway CW; Wing LL; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.
    Gibson EL; Barnfield AM; Curzon G
    Neuropharmacology; 1994; 33(3-4):457-65. PubMed ID: 7984284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.
    Vickers SP; Easton N; Webster LJ; Wyatt A; Bickerdike MJ; Dourish CT; Kennett GA
    Psychopharmacology (Berl); 2003 May; 167(3):274-80. PubMed ID: 12690422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine.
    Johnson MP; Nichols DE
    Pharmacol Biochem Behav; 1990 May; 36(1):105-9. PubMed ID: 2140899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W; Li MW; Thakali K; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
    Rothman RB; Baumann MH; Savage JE; Rauser L; McBride A; Hufeisen SJ; Roth BL
    Circulation; 2000 Dec; 102(23):2836-41. PubMed ID: 11104741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat.
    Samanin R; Mennini T; Bendotti C; Barone D; Caccia S; Garattini S
    Neuropharmacology; 1989 May; 28(5):465-9. PubMed ID: 2566947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat.
    Clifton PG; Lee MD; Dourish CT
    Psychopharmacology (Berl); 2000 Oct; 152(3):256-67. PubMed ID: 11105935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central 5-hydroxytryptamine2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat.
    Chaouloff F; Gunn SH; Young JB
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1008-16. PubMed ID: 1545373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
    Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
    Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.